Volker Knappertz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, United Kingdom
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Volker Knappertz, M.D.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Volker Knappertz

Form 4 holding EVP, Research and Development

Aurinia Pharmaceuticals Inc.

Security class
Common Stock
Shares / value
319,128
Estimated value
$1,946,681
Report date
27 Feb 2024
Price
$6.10
Ownership
Direct
Form 4 holding Chief Medical Officer

GW PHARMACEUTICALS PLC

Security class
Ordinary Shares
Shares / value
0
Estimated value
Report date
05 May 2021
Price
Ownership
Direct
Form 4 holding Chief Medical Officer

GW PHARMACEUTICALS PLC

Security class
Share Options
Shares / value
0
Estimated value
Report date
05 May 2021
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Volker Knappertz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .